Skip to main content
SpringerLink
Log in

Prostate cancer

A valuable tool for prediction of repeat biopsy pathology

  • News & Views
  • Published:

From Nature Reviews Urology

View current issue Sign up to alerts

Multiparametric MRI (mpMRI) findings are not always accurate in patients with a previous negative prostate biopsy. Truong et al. have developed a nomogram to identify patients with previous negative prostate biopsy who are at elevated risk of harbouring benign histology and should undergo repeat biopsy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bokhorst, L. P. et al. Positive predictive value of prostate biopsy indicated by prostate-specific-antigen-based prostate cancer screening: trends over time in a European randomized trial. BJU Int. 110, 1654–1660 (2012).

    Article  CAS  Google Scholar 

  2. Takenaka, A. et al. A prospective randomized comparison of diagnostic efficacy between transperineal and transrectal 12-core prostate biopsy. Prostate Cancer Prostat. Dis. 11, 134–138 (2008).

    Article  CAS  Google Scholar 

  3. Campos-Fernandes, J.-L. et al. Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy. Eur. Urol. 55, 600–609 (2009).

    Article  Google Scholar 

  4. Prostate Cancer Guidelines Panel. Prostate Cancer. European Association of Urology http://uroweb.org/guideline/prostate-cancer/ (2017).

  5. Truong, M. et al. Multi-institutional nomogram predicting benign prostate pathology on magnetic resonance/ultrasound fusion biopsy in men with a prior negative 12-core systematic biopsy. Cancer http://dx.doi.org/10.1002/cncr.31051 (2017).

  6. Rosenkrantz, A. B. et al. Proposed adjustments to PI-RADS version 2 decision rules: impact on prostate cancer detection. Radiology 283, 119–129 (2016).

    Article  Google Scholar 

  7. Thompson, J. E. et al. Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a prospective study. J. Urol. 192, 67–74 (2014).

    Article  Google Scholar 

  8. Venderink, W. et al. Results of targeted biopsy in men with magnetic resonance imaging lesions classified equivocal, likely or highly likely to be clinically significant prostate cancer. Eur. Urol. http://dx.doi.org/10.1016/j.eururo.2017.02.021 (2017).

  9. Liddell, H., Jyoti, R. & Haxhimolla, H. Z. mp-MRI prostate characterised PIRADS 3 lesions are associated with a low risk of clinically significant prostate cancer — a retrospective review of 92 biopsied PIRADS 3 lesions. Curr. Urol. 8, 96–100 (2015).

    Article  Google Scholar 

  10. Edwan, G. A. et al. Magnetic resonance imaging detected prostate evasive anterior tumours: further insights. Can. Urol. Assoc. J. 9, E267–E272 (2015).

    Article  Google Scholar 

Download references

Acknowledgements

The authors thank M. Marchioni, F. Preisser and M. Bandini for their help in researching data for the article and review and editing of the manuscript before submission.

Author information

Authors and Affiliations

  1. Pierre Karakiewicz and Sebastiano Nazzani are at the University of Montreal Health Center, Cancer Prognostics and Health Outcomes Unit, Campus St-Luc, 1058 rue St-Denis, Montréal, Québec H2X 3J4, Canada.,

    Pierre Karakiewicz & Sebastiano Nazzani

Authors
  1. Pierre Karakiewicz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sebastiano Nazzani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sebastiano Nazzani.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Karakiewicz, P., Nazzani, S. A valuable tool for prediction of repeat biopsy pathology. Nat Rev Urol 15, 140–141 (2018). https://doi.org/10.1038/nrurol.2017.216

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrurol.2017.216

  • Springer Nature Limited

This article is cited by

Search

Navigation